Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Contact:Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Christopher A. Viehbacher, President and Chief Executive Officer, will present during the 43rd Annual J.P. Morgan Healthcare Conference. The webcast will be live on Tuesday, January 14, 2024, at 12:45 p.m. ET. To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com. An archived version of the webcast will be available for at least 30 days following the presentation.
馬薩諸塞州劍橋 - 渤健公司（納斯達克：BIIB）今天宣佈，首席執行官克里斯托弗·A·維赫巴赫將在第43屆年度摩根大通醫療會議上進行演講。網絡直播將於2024年1月14日星期二下午12:45（東部時間）進行。要訪問網絡直播，請訪問渤健公司網站的投資者部分，網址爲 investors.biogen.com。直播的存檔版本將在演講後至少提供30天。
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
關於渤健公司
渤健公司成立於1978年，是一家領先的生物技術公司，開創創新科學，提供新藥來改變患者的生活，併爲股東和社區創造價值。我們運用對人類生物學的深刻理解，利用不同的手段推進首創的治療方法或療法，以提供更卓越的療效。我們的做法是承擔大膽的風險，同時平衡投資回報，以實現長期增長。
We routinely post information that may be important to investors on our website at . Follow us on social media - Facebook, LinkedIn, X, YouTube.
我們定期在我們的網站上發佈可能對投資者重要的信息。請在社交媒體上關注我們 - Facebook、LinkedIn、X、YouTube。
Contact:
聯繫：
Karen Jewell
Investor Relations
Biogen
781.464.2442
卡倫·朱爾
投資者關係
Biogen
781.464.2442
